Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swiss (SMI) Pharma Industry Analysis

UpdatedFeb 15, 2025
DataAggregated Company Financials
Companies8
  • 7D0.2%
  • 3M10.8%
  • 1Y19.6%
  • YTD11.3%

The Pharma industry is up 1.6% in the last week, with Roche Holding up 3.5%. This means that the industry has gained 22% over the past year. Earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the Swiss Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 16 Feb 2025CHF 475.3bCHF 122.3bCHF 19.1b22.9x24.9x3.9x
Tue, 14 Jan 2025CHF 440.8bCHF 120.3bCHF 21.5b18.3x20.5x3.7x
Thu, 12 Dec 2024CHF 423.4bCHF 117.9bCHF 21.1b18.1x20x3.6x
Sat, 09 Nov 2024CHF 439.1bCHF 117.4bCHF 21.0b18.9x20.9x3.7x
Mon, 07 Oct 2024CHF 445.7bCHF 115.4bCHF 19.4b21.1x23x3.9x
Wed, 04 Sep 2024CHF 471.2bCHF 114.9bCHF 19.3b22.5x24.4x4.1x
Fri, 02 Aug 2024CHF 467.4bCHF 116.5bCHF 19.7b22.6x23.8x4x
Sun, 30 Jun 2024CHF 434.0bCHF 116.4bCHF 19.8b33.7x21.9x3.7x
Tue, 28 May 2024CHF 410.2bCHF 117.4bCHF 19.9b42.7x20.6x3.5x
Thu, 25 Apr 2024CHF 394.2bCHF 113.7bCHF 20.0b37.3x19.7x3.5x
Sat, 23 Mar 2024CHF 386.2bCHF 111.7bCHF 19.3b37.5x20x3.5x
Mon, 19 Feb 2024CHF 380.8bCHF 110.4bCHF 19.7b23.9x19.3x3.4x
Wed, 17 Jan 2024CHF 416.8bCHF 120.0bCHF 18.7b27.2x22.2x3.5x
Fri, 15 Dec 2023CHF 397.8bCHF 120.2bCHF 18.8b25x21.2x3.3x
Sun, 12 Nov 2023CHF 385.0bCHF 122.6bCHF 19.1b23.4x20.2x3.1x
Tue, 10 Oct 2023CHF 407.0bCHF 121.8bCHF 18.7b26.3x21.8x3.3x
Thu, 07 Sep 2023CHF 395.6bCHF 112.4bCHF 18.0b47.6x22x3.5x
Sat, 05 Aug 2023CHF 409.2bCHF 114.6bCHF 19.2b48.3x21.3x3.6x
Mon, 03 Jul 2023CHF 421.0bCHF 115.1bCHF 18.9b36.9x22.3x3.7x
Wed, 31 May 2023CHF 426.7bCHF 115.6bCHF 18.9b38.4x22.5x3.7x
Fri, 28 Apr 2023CHF 426.2bCHF 115.1bCHF 18.9b41.2x22.6x3.7x
Sun, 26 Mar 2023CHF 394.1bCHF 116.0bCHF 19.0b40.1x20.8x3.4x
Tue, 21 Feb 2023CHF 406.8bCHF 116.1bCHF 19.0b28.5x21.4x3.5x
Thu, 19 Jan 2023CHF 437.6bCHF 116.6bCHF 34.4b23.8x12.7x3.8x
Sat, 17 Dec 2022CHF 441.7bCHF 117.5bCHF 34.8b23.1x12.7x3.8x
Mon, 14 Nov 2022CHF 450.3bCHF 118.2bCHF 35.1b23.4x12.8x3.8x
Wed, 12 Oct 2022CHF 443.6bCHF 121.4bCHF 37.4b20.7x11.9x3.7x
Fri, 09 Sep 2022CHF 450.9bCHF 120.1bCHF 36.8b21.2x12.2x3.8x
Sun, 07 Aug 2022CHF 452.8bCHF 119.7bCHF 36.6b21.1x12.4x3.8x
Tue, 05 Jul 2022CHF 453.0bCHF 118.7bCHF 37.3b27.4x12.1x3.8x
Thu, 02 Jun 2022CHF 462.7bCHF 118.9bCHF 37.4b28.8x12.4x3.9x
Sat, 30 Apr 2022CHF 496.9bCHF 119.3bCHF 37.6b31.4x13.2x4.2x
Mon, 28 Mar 2022CHF 495.7bCHF 116.9bCHF 36.4b33.6x13.6x4.2x
Wed, 23 Feb 2022CHF 468.8bCHF 116.4bCHF 36.1b19.8x13x4x
Price to Earnings Ratio

13x


Total Market Cap: CHF 468.8bTotal Earnings: CHF 36.1bTotal Revenue: CHF 116.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Pharma Industry Price to Earnings3Y Average 18.8x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 25.1x which is higher than its 3-year average PE of 18.8x.
  • The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 19% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market1.89%
Healthcare0.02%
Pharma0.22%
Pharma0.22%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ROG Roche HoldingCHF 294.501.9%
+CHF 4.4b		29.1%PE28.3x
SDZ Sandoz GroupCHF 44.571.1%
+CHF 219.4m		55.2%PS2.1x
COPN Cosmo PharmaceuticalsCHF 64.302.1%
+CHF 20.9m		-0.9%PE15.7x
NWRN Newron PharmaceuticalsCHF 10.124.1%
+CHF 8.0m		21.9%PS30.7x
DESN Dottikon ES HoldingCHF 214.000.2%
+CHF 6.9m		-8.9%PE39.2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ROG

CHF 294.50

Roche Holding

7D

1.9%

1Y

29.1%

GALD

CHF 112.54

Galderma Group

7D

-2.7%

1Y

n/a

DESN

CHF 214.00

Dottikon ES Holding

7D

0.2%

1Y

-8.9%

Dottikon ES Holding AG's (VTX:DESN) Business Is Yet to Catch Up With Its Share Price

Feb 12
Dottikon ES Holding AG's (VTX:DESN) Business Is Yet to Catch Up With Its Share Price

COPN

CHF 64.30

Cosmo Pharmaceuticals

7D

2.1%

1Y

-0.9%

NOVN

CHF 95.37

Novartis

7D

-1.5%

1Y

7.8%

SDZ

CHF 44.57

Sandoz Group

7D

1.1%

1Y

55.2%

NWRN

CHF 10.12

Newron Pharmaceuticals

7D

4.1%

1Y

21.9%

ADXN

CHF 0.059

Addex Therapeutics

7D

-4.2%

1Y

-18.1%

CURN

CHF 10.30

Curatis Holding

7D

-18.3%

1Y

n/a